H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act of 2021

About This Bill

  • Introduced April 28, 2021
  • Latest Major Action Sept. 29, 2021

Bill Version

Bill Summary

Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 This bill prohibits product hopping by drug manufacturers and authorizes the Federal Trade Commission to sue in court or institute administrative proceedings to enforce this prohibition. Generally, product-hopping describes a situation where, when the patents on a reference drug (or biological product) expire, the manufacturer switches to a follow-on product that...

(Source: Library of Congress)

Bill Actions

Date Description
Sept. 29, 2021
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 27 - 16.
Sept. 29, 2021
Committee Consideration and Mark-up Session Held.
April 28, 2021
Referred to the House Committee on the Judiciary.
April 28, 2021

Introduced in the House by David Cicilline (D-R.I.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page